Annabel Borley Selected Research

Lymphoma (Lymphomas)

1/2022

Rationale and Design of the Cardiac CARE Trial: A Randomized Trial of Troponin-Guided Neurohormonal Blockade for the Prevention of Anthracycline Cardiotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annabel Borley Research Topics

Disease

6	Breast Neoplasms (Breast Cancer) 11/2023 - 09/2019
2	Triple Negative Breast Neoplasms 04/2024 - 04/2024
2	Left Ventricular Dysfunction 11/2023 - 01/2022
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2023 - 01/2022
2	Cardiotoxicity 11/2023 - 01/2022
2	Neoplasms (Cancer) 06/2022 - 09/2021
1	Neutropenia 01/2022
1	Febrile Neutropenia 01/2022
1	Fever (Fevers) 01/2022
1	Aortitis 01/2022
1	Vasculitis (Vasculitides) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Heart Failure 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Phlebitis 09/2019

Drug/Important Bio-Agent (IBA)

3	AnthracyclinesIBA 04/2024 - 01/2022
2	TroponinIBA 11/2023 - 01/2022
2	candesartanIBA 11/2023 - 01/2022
2	Troponin IIBA 11/2023 - 01/2022
2	Carvedilol (Coreg)FDA LinkGeneric 11/2023 - 01/2022
1	sacituzumab govitecanIBA 04/2024
1	olaparibIBA 04/2024
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2024
1	Carboplatin (JM8)FDA LinkGeneric 04/2024
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2022
1	eribulin FDA Link 01/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2021
1	Celecoxib (Celebrex)FDA Link 09/2021
1	Estrogen ReceptorsIBA 09/2021
1	Epirubicin (Ellence)FDA LinkGeneric 09/2019

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 04/2024 - 09/2019
3	Therapeutics 11/2023 - 09/2021
1	Non-Medical Prescribing 06/2022
1	Adjuvant Chemotherapy 01/2022
1	Intravenous Administration 09/2019